Without knowing details, it is almost impossible to give a serious estimation for a pps target. We don't even have the slightest idea what these "discussions" with an "international Pharma Giant" are all about. For now all remains pure fantasy. Nevertheless in my opinion the current price is still very cheap, no matter what the intentions of this "Giant" may be. For me TRAB is a long-term investment and not a short-term play.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.